Friday, July 20, 2018
 
 
Company News: Page (1) of 1 - 06/28/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Melbourne, Florida Top Plastic Surgeon Offers Better CoolSculpting Results with CoolAdvantage
Dr. Mauricio Castellon, founder of Castellon Plastic Surgery Center and MedSpa is one of a select group of practices in Florida to bring patients CoolSculpting's innovative new applicator, the Coo...
(June 28, 2018)

MELBOURNE, Fla., June 28, 2018 /PRNewswire-PRWeb/ -- Castellon Plastic Surgery announced today the availability of CoolSculpting's newest applicator, the CoolAdvantage. Recently redesigned for maximum results, the CoolAdvantage brings patients more effective fat reduction and faster treatments than seen with traditional CoolSculpting tools. Board-certified plastic surgeon, Dr. Mauricio Castellon was the first plastic surgeon to bring CoolSculpting to Brevard County and is one of an elite group of cosmetic practices to offer this break-through applicator, CoolAdvantage.

CoolSculpting is an FDA-cleared noninvasive fat reduction procedure to reduce stubborn fatty tissue using Cryolipolysis, which freezes fat cells and damages their structures. Your body then processes the dead cells and flushes them naturally. The number of treatments necessary to get the results you desire depends entirely on person's body type and the area that they would like to sculpt. The CoolAdvantage applicator merges uniform cooling and increased tissue contact to shorten treatment times. Procedures using the CoolAdvantage take 35 minutes, reduced from the 60-minute treatment using CoolSculpting's original hand pieces. The enhanced cup design, created specifically for the individual area to be treated, means increased contact with fatty tissue, providing smoother results for a larger area and a more comfortable procedure. Patients report 45% improvement in comfort scores. These enhancements translate to faster and more effective results.

"Over the last eight years, CoolSculpting has become one of the most popular nonsurgical fat elimination techniques in the aesthetic market," said Dr. Mauricio Castellon. "I am thrilled to offer my patients a proven non-invasive solution that will reduce treatment time with greater comfort."



Castellon Plastic Surgery Center will host a CoolEvent on July 11, 2018 that will allow consumers to learn more about CoolSculpting and the newest CoolAdvantage applicator. Treatments will be performed by Dr. Castellon's registered nurse and a CoolSculpting representative will be available for questions. For more information about the CoolEvent, please visit the website at http://www.drcastellon.com/events.

About the CoolSculpting® Procedure
CoolSculpting is a non-surgical, clinically proven procedure that selectively reduces unwanted fat using a patented cooling technology. Cleared by the FDA, CoolSculpting works by gently cooling targeted fat cells in the body to induce a natural, controlled elimination of fat cells without affecting surrounding tissue, and the treated fat cells are gone for good. Millions of CoolSculpting treatments have been performed by more than 5,700 CoolSculpting systems in over 80 countries. Market research indicates up to a 95 percent customer satisfaction rate with the CoolSculpting procedure. CoolSculpting is available through an elite network of CoolSculpting Centers worldwide. Dermatologists, plastic surgeons and leading aesthetic specialists that offer CoolSculpting can be found at http://www.coolsculpting.com.

Be sure to follow CoolSculpting on Facebook, Twitter, Pinterest and YouTube.

About Castellon Plastic Surgery Center
Mauricio J. Castellon, MD, FACS is the founder of the Castellon Plastic Surgery Center and MedSpa based in Melbourne, Florida. He is board-certified by the American Board of Plastic Surgery and is an active member of both the American Society of Plastic Surgeons, and the American Society of Aesthetic Plastic Surgery. He currently serves as the president of the Florida Society of Plastic Surgeons, and chairman of Plastic Surgery for Holmes Regional Medical Center in Melbourne, Florida. His training includes general, plastic and reconstructive surgery from the Albany Medical Center in New York. He completed his undergraduate degree at the University of Florida, followed by his Doctor of Medicine degree from the Ponce School of Medicine. Castellon Plastic Surgery Center and MedSpa offers Brevard County and Central Florida a unique expertise in full-body plastic surgery, reconstruction, rejuvenation, minimally-invasive/non-invasive cosmetic procedures, and non-surgical skin care treatments. For more information about Castellon Plastic Surgery Center, visit http://www.drcastellon.com or follow us on Facebook, Instagram, Twitter, or Google+.

SOURCE: CoolSculpting

 

SOURCE CoolSculpting

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Medicine,Surgery,Surgery,Medication,Physician,Nurse,Science,Medical,Medical Professionals,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research
  • Wireless Health Market To Witness Enhanced Growth Owing To Rising Application of Wireless Health Devices And Growing Patient-Centric Methodology Till 2025 | Million Insights

    Cancer
  • Mesothelioma is a Deadly Cancer and it’s Completely Preventable
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally - QYResearch.com
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines